Less is more: Lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy

Current Opinion in Immunology

Volumn 17, Issue 2, 2005, Pages 195-201

  Wrzesinski, Claudia ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CYTOKINE; GLYCOPROTEIN GP 100; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR VACCINE;

ADOPTIVE IMMUNOTHERAPY; AUTOTRANSPLANTATION; BINDING AFFINITY; CANCER IMMUNOLOGY; CELL PROLIFERATION; CELL TRANSFER; DNA MODIFICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEOSTASIS; HOST; HUMAN; IMMUNE SYSTEM; MELANOMA; METASTASIS; MOLECULE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VACCINATION;

EID: 14844302392     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.02.002     Document Type: Review

References (60)

1. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat Med 10 2004 909 915
2. Z. Yu, M.R. Theoret, C.E. Touloukian, D.R. Surman, S.C. Garman, L. Feigenbaum, T.K. Baxter, B.M. Baker, and N.P. Restifo Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance J Clin Invest 114 2004 551 559
3. Overwijk WW: Breaking tolerance in cancer immunotherapy: time to ACT. Curr Opin Immunol 2005, 17: in press.
4. M.E. Dudley, J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, and A.M. Hubicki Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 2002 850 854
5. S.A. Rosenberg, and M.E. Dudley Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes Proc Natl Acad Sci USA 101 Suppl 2 2004 14639 14645
6. K. Murali-Krishna, and R. Ahmed Cutting edge: naive T cells masquerading as memory cells J Immunol 165 2000 1733 1737
7. A.W. Goldrath, L.Y. Bogatzki, and M.J. Bevan Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation J Exp Med 192 2000 557 564
8. B.K. Cho, V.P. Rao, Q. Ge, H.N. Eisen, and J. Chen Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells J Exp Med 192 2000 549 556
9. W.C. Kieper, and S.C. Jameson Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands Proc Natl Acad Sci USA 96 1999 13306 13311
10. W. Dummer, A.G. Niethammer, R. Baccala, B.R. Lawson, N. Wagner, R.A. Reisfeld, and A.N. Theofilopoulos T cell homeostatic proliferation elicits effective antitumor autoimmunity J Clin Invest 110 2002 185 192
11. C. King, A. Ilic, K. Koelsch, and N. Sarvetnick Homeostatic expansion of T cells during immune insufficiency generates autoimmunity Cell 117 2004 265 277
12. S. Oehen, and K. Brduscha-Riem Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies? Eur J Immunol 29 1999 608 614
13. W.W. Overwijk, M.R. Theoret, S.E. Finkelstein, D.R. Surman, L.A. de Jong, F.A. Vyth-Dreese, T.A. Dellemijn, P.A. Antony, P.J. Spiess, and D.C. Palmer Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells J Exp Med 198 2003 569 580
14. C. Viret, F.S. Wong, and C.A. Janeway Jr. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition Immunity 10 1999 559 568
15. A.W. Goldrath, and M.J. Bevan Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts Immunity 11 1999 183 190
16. B. Ernst, D.S. Lee, J.M. Chang, J. Sprent, and C.D. Surh The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery Immunity 11 1999 173 181
17. J. Bender, T. Mitchell, J. Kappler, and P. Marrack CD4+ T cell division in irradiated mice requires peptides distinct from those responsible for thymic selection J Exp Med 190 1999 367 374
18. Q. Ge, V.P. Rao, B.K. Cho, H.N. Eisen, and J. Chen Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors Proc Natl Acad Sci USA 98 2001 1728 1733
19. S.R. Clarke, and A.Y. Rudensky Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes J Immunol 165 2000 2458 2464
20. J.R. Dorfman, I. Stefanova, K. Yasutomo, and R.N. Germain CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling Nat Immunol 1 2000 329 335
21. G. Kassiotis, R. Zamoyska, and B. Stockinger Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells J Exp Med 197 2003 1007 1016
22. W.C. Kieper, J.T. Burghardt, and C.D. Surh A role for TCR affinity in regulating naive T cell homeostasis J Immunol 172 2004 40 44
23. B. Min, G. Foucras, M. Meier-Schellersheim, and W.E. Paul Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire Proc Natl Acad Sci USA 101 2004 3874 3879
24. N.L. La Gruta, I.R. Driel, and P.A. Gleeson Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire Eur J Immunol 30 2000 3380 3386
25. A.E. Troy, and H. Shen Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition J Immunol 170 2003 672 676
26. C.T. Moses, K.M. Thorstenson, S.C. Jameson, and A. Khoruts Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells Proc Natl Acad Sci USA 100 2003 1185 1190
27. P.F. Robbins, M.E. Dudley, J. Wunderlich, M. El-Gamil, Y.F. Li, J. Zhou, J. Huang, D.J. Powell Jr., and S.A. Rosenberg Cutting Edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy J Immunol 173 2004 7125 7130 Lymphodepletion increases the persistence of adoptively transferred T cells. This paper furthermore shows a strong correlation between the rate of persistence of adoptively transferred T cells and induction of objective responses.
28. M. Prlic, B.R. Blazar, A. Khoruts, T. Zell, and S.C. Jameson Homeostatic expansion occurs independently of costimulatory signals J Immunol 167 2001 5664 5668
29. B.R. Blazar, B.S. Kwon, A. Panoskaltsis-Mortari, K.B. Kwak, J.J. Peschon, and P.A. Taylor Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients J Immunol 166 2001 3174 3183
30. O. Li, P. Zheng, and Y. Liu CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host J Exp Med 200 2004 1083 1089
31. K.S. Schluns, W.C. Kieper, S.C. Jameson, and L. Lefrancois Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo Nat Immunol 1 2000 426 432
32. C.C. Ku, M. Murakami, A. Sakamoto, J. Kappler, and P. Marrack Control of homeostasis of CD8+ memory T cells by opposing cytokines Science 288 2000 675 678
33. J.T. Tan, E. Dudl, E. LeRoy, R. Murray, J. Sprent, K.I. Weinberg, and C.D. Surh IL-7 is critical for homeostatic proliferation and survival of naive T cells Proc Natl Acad Sci USA 98 2001 8732 8737
34. A.W. Goldrath, P.V. Sivakumar, M. Glaccum, M.K. Kennedy, M.J. Bevan, C. Benoist, D. Mathis, and E.A. Butz Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells J Exp Med 195 2002 1515 1522
35. B. Seddon, and R. Zamoyska TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells J Immunol 169 2002 3752 3759
36. K.L. Komschlies, T.A. Gregorio, M.E. Gruys, T.C. Back, C.R. Faltynek, and R.H. Wiltrout Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases J Immunol 152 1994 5776 5784
37. M. Moniuszko, T. Fry, W.P. Tsai, M. Morre, B. Assouline, P. Cortez, M.G. Lewis, S. Cairns, C. Mackall, and G. Franchini Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo J Virol 78 2004 9740 9749 This suggests that the application of IL-7 together with adoptively transferred tumor-reactive T cells in a lymphopenic host can augment tumor treatment potential.
38. L.A. Geiselhart, C.A. Humphries, T.A. Gregorio, S. Mou, J. Subleski, and K.L. Komschlies IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation J Immunol 166 2001 3019 3027
39. L. Vivien, C. Benoist, and D. Mathis T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo Int Immunol 13 2001 763 768
40. T.E. Boursalian, and K. Bottomly Survival of naive CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu J Immunol 162 1999 3795 3801
41. D.C. Lenz, S.K. Kurz, E. Lemmens, S.P. Schoenberger, J. Sprent, M.B. Oldstone, and D. Homann IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory Proc Natl Acad Sci USA 101 2004 9357 9362
42. P.R. Burkett, R. Koka, M. Chien, S. Chai, D.L. Boone, and A. Ma Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis J Exp Med 200 2004 825 834
43. C.A. Klebanoff, S.E. Finkelstein, D.R. Surman, M.K. Lichtman, L. Gattinoni, M.R. Theoret, N. Grewal, P.J. Spiess, P.A. Antony, and D.C. Palmer IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells Proc Natl Acad Sci USA 101 2004 1969 1974 The application of IL-15 as supportive cytokine in ACT could circumvent negative effects of the IL-2, which has been used to date, in a similar way to the induction of regulatory T cells.
44. + cells, and can augment ACT when administered in vivo.
45. M.J. Turk, J.A. Guevara-Patino, G.A. Rizzuto, M.E. Engelhorn, and A.N. Houghton Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells J Exp Med 200 2004 771 782
46. D. Golgher, E. Jones, F. Powrie, T. Elliott, and A. Gallimore Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens Eur J Immunol 32 2002 3267 3275
47. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
48. N. Casares, L. Arribillaga, P. Sarobe, J. Dotor, A. Lopez-Diaz de Cerio, I. Melero, J. Prieto, F. Borras-Cuesta, and J.J. Lasarte CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination J Immunol 171 2003 5931 5939
49. + T cells can be generated from tumor-infiltrating lymphocytes (TILs) in cancer patients. TILs showed suppressor activity and therefore might substantially inhibit T-cell anti-tumor action at the tumor site.
50. + Treg cells from ovarian cancer patients suppress tumor-specific T-cell immunity, influence tumor growth and are associated with reduced survival.
51. E.Y. Woo, C.S. Chu, T.J. Goletz, K. Schlienger, H. Yeh, G. Coukos, S.C. Rubin, L.R. Kaiser, and C.H. June Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Res 61 2001 4766 4772
52. E.Y. Woo, H. Yeh, C.S. Chu, K. Schlienger, R.G. Carroll, J.L. Riley, L.R. Kaiser, and C.H. June Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation J Immunol 168 2002 4272 4276
53. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J.A. Drebin, S.M. Strasberg, T.J. Eberlein, and P.S. Goedegebuure Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761
54. E. Lorenz, D. Uphoff, T.R. Reid, and E. Shelton Modification of irradiation injury in mice and guinea pigs by bone marrow injections J Natl Cancer Inst 12 1951 197 201
55. Y. Cui, E. Kelleher, E. Straley, E. Fuchs, K. Gorski, H. Levitsky, I. Borrello, C.I. Civin, S.P. Schoenberger, and L. Cheng Immunotherapy of established tumors using bone marrow transplantation with antigen gene-modified hematopoietic stem cells Nat Med 9 2003 952 958
56. R.P. Sutmuller, L.M. van Duivenvoorde, A. van Elsas, T.N. Schumacher, M.E. Wildenberg, J.P. Allison, R.E. Toes, R. Offringa, and C.J. Melief Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses J Exp Med 194 2001 823 832
57. S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
58. P.J. Coffer, and B.M. Burgering Forkhead-box transcription factors and their role in the immune system Nat Rev Immunol 4 2004 889 899
59. + T cells (T regulatory cells). Therefore, for an optimal tumor treatment with adoptive T cell transfer the absence of inhibitory effects of T regulatory cells is required.
60. C.A. Klebanoff, H.T. Khong, P.A. Antony, D.C. Palmer, and N.P. Restifo Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy Trends Immunol 26 2005 111 117